Related Experiment Videos
Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions
L M Musten1, P Firestone, S Pisterman
1School of Psychology, University of Ottawa, Ontario, Canada.
Insights
Methylphenidate effectively improves attention and impulsivity in preschoolers with ADHD. While it enhances cognitive function, it does not impact compliance with parental requests.
Area of Science:
- Pediatric Psychiatry
- Neurodevelopmental Disorders
- Pharmacology
Background:
- Attention-deficit hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder.
- Early intervention in preschool-aged children with ADHD is crucial for long-term outcomes.
- The efficacy and safety of methylphenidate in very young children require further investigation.
Purpose of the Study:
- To evaluate the effects of methylphenidate on cognitive and behavioral functioning in preschool children with ADHD.
- To assess the implications of methylphenidate treatment for compliance in this age group.
- To examine potential dose-related side effects of methylphenidate.
Main Methods:
- A double-blind, placebo-controlled study involving 31 children aged 4-6 years diagnosed with ADHD.
- Administration of placebo, 0.3 mg/kg, and 0.5 mg/kg of methylphenidate twice daily.
- Assessment using cognitive tests, parent rating scales, and interactive tasks with mothers.
Main Results:
- Methylphenidate improved attention and reduced impulsivity, as evidenced by cognitive tests and parent reports.
- Children showed enhanced attentional abilities and productivity in interactive settings.
- No significant changes in compliance with parental requests were observed.
- Mild side effects were noted, particularly at the higher dosage.
Conclusions:
- Methylphenidate is a viable treatment option for improving the functioning of preschool-aged children with ADHD.
- The therapeutic effects are comparable to those observed in school-aged children.
- Further research is needed to address compliance challenges in methylphenidate-treated preschoolers.
Objective:
To report on implications for methylphenidate treatment of this very young age group and the need to examine factors related to achieving compliance.
Method:
Thirty-one children with attention-deficit hyperactivity disorder (ADHD), aged 4 to 6 years, participated in a double-blind, placebo-controlled study using placebo, 0.3 mg/kg, and 0.5 mg/kg of methylphenidate twice per day.
Results:
Improvements related to medication were obtained on cognitive tests of attention and impulsivity as well as behaviors assessed by parent rating scales. In an interactive setting with their mothers, attentional abilities and the children's ability to work more productively also showed improvement. However, no changes were obtained with respect to the children's tendency to comply with parental requests. Side effects increased slightly with the high dosage of medication but remained mild.
Conclusion:
The results suggest that methylphenidate can be used to improve the functioning of preschool-age children with ADHD, in a manner similar to their school-age counterparts.